Disclosures for "Participant-specific interrogation of population-based data to predict cognitive decline from neuropsychiatric symptoms and neuroimaging biomarkers: A machine learning approach")
-
Mr. Shah has nothing to disclose.
-
Jeremy Syrjanen has nothing to disclose.
-
Dr. Krell-Roesch has nothing to disclose.
-
The institution of Walter Kremers has received research support from Biogen.
-
Dr. Vemuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Miller Medical Communications Inc.. The institution of Dr. Vemuri has received research support from NIH.
-
The institution of Dr. Vassilaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd . Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from Biogen. The institution of Dr. Vassilaki has received research support from F. Hoffmann-La Roche Ltd . The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
-
Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Forzani has received research support from NIH. The institution of Dr. Forzani has received research support from NSF. Dr. Forzani has received intellectual property interests from a discovery or technology relating to health care. Dr. Forzani has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with Arizona State University.
-
Dr. Wu has nothing to disclose.
-
The institution of Dr. Geda has received research support from NIH.